| abstract |
The invention relates to novel products of formula (I); in which R represents H1 HaI or AIk; A represents NH or S; R5 represents H or alk optionally substituted by one or more Hal; R6 represents aryl or optionally heteroaryl substituted; W represents H or COR7 wherein R7 represents cycloalkyl, optionally substituted alkyl, optionally alkoxy substituted or NR1R2 with one of R1 and R2 represents H or alk and the other of R1 and R2 represents cycloalkyl or optionally alkyl substituted; or else R1 and R2 form with N to which they are bound a radical cyclic optionally containing one or more O, S, N and NH, optionally substituted; these products being in all forms isomers and salts, as medicaments in particular as CMet inhibitors for the treatment of cancer. |